Ascendis Pharma A/S
NASDAQ:ASND
Ascendis Pharma A/S
Free Cash Flow
Ascendis Pharma A/S
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ascendis Pharma A/S
NASDAQ:ASND
|
Free Cash Flow
-€321.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Free Cash Flow
kr5.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Free Cash Flow
-kr449.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-10%
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Free Cash Flow
kr1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
78%
|
Bioporto A/S
CSE:BIOPOR
|
Free Cash Flow
-kr49.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
Saniona AB
STO:SANION
|
Free Cash Flow
-kr85.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
See Also
What is Ascendis Pharma A/S's Free Cash Flow?
Free Cash Flow
-321.8m
EUR
Based on the financial report for Mar 31, 2024, Ascendis Pharma A/S's Free Cash Flow amounts to -321.8m EUR.
What is Ascendis Pharma A/S's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-14%
Over the last year, the Free Cash Flow growth was 39%. The average annual Free Cash Flow growth rates for Ascendis Pharma A/S have been -2% over the past three years , -14% over the past five years .